Literature DB >> 16437662

Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study.

Andreas Leodolter1, Marc Nocon, Michael Kulig, Stefan N Willich, Peter Malfertheiner, Joachim Labenz.   

Abstract

AIM: To study the association of gastro-esophageal reflux disease (GERD) with the absence from work and to estimate the extent of loss in gross domestic product due to inability to work.
METHODS: Analysis was based on the prospectively gathered data of a large European cohort study involving 6 215 symptomatic GERD patients (ProGERD). Among these patients, 2 871 were initially employed. The calculation of the loss of gross domestic product was based on the assumption that the prevalence of GERD was about 15% in Germany. According to the German Federal Statistical Office, the mean gross wage of employees was 150 EUR/d in 2002.
RESULTS: The data of 2 078 employed patients who were prospectively followed up for over 2 years were analyzed. At study entry, the patients reported a mean of 1.8 d per year of inability to work. During the prospective follow-up under routine clinical care, the proportion of patients reporting days with inability to work decreased from 14% to 6% and the mean number of days per year with inability to work decreased to 0.9 d. Assuming a prevalence of troublesome GERD of 15% in the employed German population, the loss of gross domestic product amounted to 668 million EUR/year in Germany.
CONCLUSION: GERD causes a relevant impairment on the national economics by absence from work. The presented data demonstrate the importance of GERD, not only for patients and health insurance companies, but also for the community at large.

Entities:  

Mesh:

Year:  2005        PMID: 16437662      PMCID: PMC4725079          DOI: 10.3748/wjg.v11.i45.7148

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  A practical guide for calculating indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

3.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

4.  Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease.

Authors:  C Valle; F Broglia; A Pistorio; C Tinelli; M Perego
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

5.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

6.  Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization.

Authors:  C J Henke; T R Levin; J M Henning; L P Potter
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

7.  The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.

Authors:  C Farup; L Kleinman; S Sloan; D Ganoczy; E Chee; C Lee; D Revicki
Journal:  Arch Intern Med       Date:  2001-01-08

8.  Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life.

Authors:  P Wahlqvist
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

9.  Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life.

Authors:  L Frank; L Kleinman; D Ganoczy; K McQuaid; S Sloan; A Eggleston; G Tougas; C Farup
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

10.  Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.

Authors:  M Kulig; A Leodolter; M Vieth; E Schulte; D Jaspersen; J Labenz; T Lind; W Meyer-Sabellek; P Malfertheiner; M Stolte; S N Willich
Journal:  Aliment Pharmacol Ther       Date:  2003-10-15       Impact factor: 8.171

View more
  1 in total

1.  Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany.

Authors:  M Gross; U Beckenbauer; J Burkowitz; H Walther; B Brueggenjuergen
Journal:  Eur J Med Res       Date:  2010-03-30       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.